Reviews Mithracin


No reviews yet.

Mithracin Drug Description


DRUG DESCRIPTION



What are the possible side effects of plicamycin (Mithracin)?

If you experience any of the following serious side effects, seek emergency medical attention or contact your doctor immediately:

an allergic reaction (shortness of breath; closing of your throat; difficulty breathing; swelling of your lips, face, or tongue; or hives);
blood in the urine;
black or tarry stools;
signs of infection such as fever; chills, or sore throat;
nose bleed (epistaxis) or vomiting blood (hematemesis); or
unusual...
Read All Potential Side Effects for Mithracin »



WARNING IT IS RECOMMENDED THAT MITHRACIN (plicamycin) BE ADMINISTERED ONLY TO HOSPITALIZED PATIENTS BY OR UNDER THE SUPERVISION OF A QUALIFIED PHYSICIAN WHO IS EXPERIENCED IN THE USE OF CANCER CHEMOTHERAPEUTIC AGENTS, BECAUSE OF THE POSSIBILITY OF SEVERE REACTIONS. FACILITIES FOR THE DETERMINATION OF NECESSARY LABORATORY STUDIES MUST BE AVAILABLE.
SEVERE THROMBOCYTOPENIA, A HEMORRHAGIC TENDENCY AND EVEN DEATH MAY RESULT FROM THE USE OF MITHRACIN. ALTHOUGH SEVERE TOXICITY IS MORE APT TO OCCUR IN PATIENTS WHO HAVE FAR-ADVANCED DISEASE OR ARE OTHERWISE CONSIDERED POOR RISKS FOR THERAPY, SERIOUS TOXICITY MAY ALSO OCCASIONALLY OCCUR EVEN IN PATIENTS WHO ARE IN RELATIVELY GOOD CONDITION.
IN THE TREATMENT OF EACH PATIENT, THE PHYSICIAN MUST WEIGH CAREFULLY THE POSSIBILITY OF ACHIEVING THERAPEUTIC BENEFIT VERSUS THE RISK OF TOXICITY WHICH MAY OCCUR WITH MITHRACIN THERAPY. THE FOLLOWING DATA CONCERNING THE USE OF MITHRACIN IN THE TREATMENT OF TESTICULAR TUMORS, HYPERCALCEMIC AND/OR HYPERCALCIURIC CONDITIONS ASSOCIATED WITH VARIOUS ADVANCED MALIGNANCIES, SHOULD BE THOROUGHLY REVIEWED BEFORE ADMINISTERING THIS COMPOUND.
 
Mithracin (plicamycin) is a yellow crystalline compound which is produced by a microorganism, Streptomyces plicatus. Mithracin is available in vials as a freeze-dried, sterile preparation for intravenous administration. Each vial contains 2500 mcg (2.5 mg) of Mithracin with 100 mg of mannitol and sufficient disodium phosphate to adjust to pH 7. After reconstitution with sterile water for injection, the solution has a pH of 7. The drug is unstable in acid solutions with a pH below 4.
Mithracin is an antineoplastic agent. It has an empirical formula of C 52 H 76 O 24 .Last reviewed on RxList: 12/8/2004




Mithracin Drug Description


DRUG DESCRIPTION



What are the possible side effects of plicamycin (Mithracin)?

If you experience any of the following serious side effects, seek emergency medical attention or contact your doctor immediately:

an allergic reaction (shortness of breath; closing of your throat; difficulty breathing; swelling of your lips, face, or tongue; or hives);
blood in the urine;
black or tarry stools;
signs of infection such as fever; chills, or sore throat;
nose bleed (epistaxis) or vomiting blood (hematemesis); or
unusual...
Read All Potential Side Effects for Mithracin »



WARNING IT IS RECOMMENDED THAT MITHRACIN (plicamycin) BE ADMINISTERED ONLY TO HOSPITALIZED PATIENTS BY OR UNDER THE SUPERVISION OF A QUALIFIED PHYSICIAN WHO IS EXPERIENCED IN THE USE OF CANCER CHEMOTHERAPEUTIC AGENTS, BECAUSE OF THE POSSIBILITY OF SEVERE REACTIONS. FACILITIES FOR THE DETERMINATION OF NECESSARY LABORATORY STUDIES MUST BE AVAILABLE.
SEVERE THROMBOCYTOPENIA, A HEMORRHAGIC TENDENCY AND EVEN DEATH MAY RESULT FROM THE USE OF MITHRACIN. ALTHOUGH SEVERE TOXICITY IS MORE APT TO OCCUR IN PATIENTS WHO HAVE FAR-ADVANCED DISEASE OR ARE OTHERWISE CONSIDERED POOR RISKS FOR THERAPY, SERIOUS TOXICITY MAY ALSO OCCASIONALLY OCCUR EVEN IN PATIENTS WHO ARE IN RELATIVELY GOOD CONDITION.
IN THE TREATMENT OF EACH PATIENT, THE PHYSICIAN MUST WEIGH CAREFULLY THE POSSIBILITY OF ACHIEVING THERAPEUTIC BENEFIT VERSUS THE RISK OF TOXICITY WHICH MAY OCCUR WITH MITHRACIN THERAPY. THE FOLLOWING DATA CONCERNING THE USE OF MITHRACIN IN THE TREATMENT OF TESTICULAR TUMORS, HYPERCALCEMIC AND/OR HYPERCALCIURIC CONDITIONS ASSOCIATED WITH VARIOUS ADVANCED MALIGNANCIES, SHOULD BE THOROUGHLY REVIEWED BEFORE ADMINISTERING THIS COMPOUND.
 
Mithracin (plicamycin) is a yellow crystalline compound which is produced by a microorganism, Streptomyces plicatus. Mithracin is available in vials as a freeze-dried, sterile preparation for intravenous administration. Each vial contains 2500 mcg (2.5 mg) of Mithracin with 100 mg of mannitol and sufficient disodium phosphate to adjust to pH 7. After reconstitution with sterile water for injection, the solution has a pH of 7. The drug is unstable in acid solutions with a pH below 4.
Mithracin is an antineoplastic agent. It has an empirical formula of C 52 H 76 O 24 .Last reviewed on RxList: 12/8/2004




Mithracin Drug Description


DRUG DESCRIPTION



What are the possible side effects of plicamycin (Mithracin)?

If you experience any of the following serious side effects, seek emergency medical attention or contact your doctor immediately:

an allergic reaction (shortness of breath; closing of your throat; difficulty breathing; swelling of your lips, face, or tongue; or hives);
blood in the urine;
black or tarry stools;
signs of infection such as fever; chills, or sore throat;
nose bleed (epistaxis) or vomiting blood (hematemesis); or
unusual...
Read All Potential Side Effects for Mithracin »



WARNING IT IS RECOMMENDED THAT MITHRACIN (plicamycin) BE ADMINISTERED ONLY TO HOSPITALIZED PATIENTS BY OR UNDER THE SUPERVISION OF A QUALIFIED PHYSICIAN WHO IS EXPERIENCED IN THE USE OF CANCER CHEMOTHERAPEUTIC AGENTS, BECAUSE OF THE POSSIBILITY OF SEVERE REACTIONS. FACILITIES FOR THE DETERMINATION OF NECESSARY LABORATORY STUDIES MUST BE AVAILABLE.
SEVERE THROMBOCYTOPENIA, A HEMORRHAGIC TENDENCY AND EVEN DEATH MAY RESULT FROM THE USE OF MITHRACIN. ALTHOUGH SEVERE TOXICITY IS MORE APT TO OCCUR IN PATIENTS WHO HAVE FAR-ADVANCED DISEASE OR ARE OTHERWISE CONSIDERED POOR RISKS FOR THERAPY, SERIOUS TOXICITY MAY ALSO OCCASIONALLY OCCUR EVEN IN PATIENTS WHO ARE IN RELATIVELY GOOD CONDITION.
IN THE TREATMENT OF EACH PATIENT, THE PHYSICIAN MUST WEIGH CAREFULLY THE POSSIBILITY OF ACHIEVING THERAPEUTIC BENEFIT VERSUS THE RISK OF TOXICITY WHICH MAY OCCUR WITH MITHRACIN THERAPY. THE FOLLOWING DATA CONCERNING THE USE OF MITHRACIN IN THE TREATMENT OF TESTICULAR TUMORS, HYPERCALCEMIC AND/OR HYPERCALCIURIC CONDITIONS ASSOCIATED WITH VARIOUS ADVANCED MALIGNANCIES, SHOULD BE THOROUGHLY REVIEWED BEFORE ADMINISTERING THIS COMPOUND.
 
Mithracin (plicamycin) is a yellow crystalline compound which is produced by a microorganism, Streptomyces plicatus. Mithracin is available in vials as a freeze-dried, sterile preparation for intravenous administration. Each vial contains 2500 mcg (2.5 mg) of Mithracin with 100 mg of mannitol and sufficient disodium phosphate to adjust to pH 7. After reconstitution with sterile water for injection, the solution has a pH of 7. The drug is unstable in acid solutions with a pH below 4.
Mithracin is an antineoplastic agent. It has an empirical formula of C 52 H 76 O 24 .Last reviewed on RxList: 12/8/2004




Mithracin Drug Description


DRUG DESCRIPTION



What are the possible side effects of plicamycin (Mithracin)?

If you experience any of the following serious side effects, seek emergency medical attention or contact your doctor immediately:

an allergic reaction (shortness of breath; closing of your throat; difficulty breathing; swelling of your lips, face, or tongue; or hives);
blood in the urine;
black or tarry stools;
signs of infection such as fever; chills, or sore throat;
nose bleed (epistaxis) or vomiting blood (hematemesis); or
unusual...
Read All Potential Side Effects for Mithracin »



WARNING IT IS RECOMMENDED THAT MITHRACIN (plicamycin) BE ADMINISTERED ONLY TO HOSPITALIZED PATIENTS BY OR UNDER THE SUPERVISION OF A QUALIFIED PHYSICIAN WHO IS EXPERIENCED IN THE USE OF CANCER CHEMOTHERAPEUTIC AGENTS, BECAUSE OF THE POSSIBILITY OF SEVERE REACTIONS. FACILITIES FOR THE DETERMINATION OF NECESSARY LABORATORY STUDIES MUST BE AVAILABLE.
SEVERE THROMBOCYTOPENIA, A HEMORRHAGIC TENDENCY AND EVEN DEATH MAY RESULT FROM THE USE OF MITHRACIN. ALTHOUGH SEVERE TOXICITY IS MORE APT TO OCCUR IN PATIENTS WHO HAVE FAR-ADVANCED DISEASE OR ARE OTHERWISE CONSIDERED POOR RISKS FOR THERAPY, SERIOUS TOXICITY MAY ALSO OCCASIONALLY OCCUR EVEN IN PATIENTS WHO ARE IN RELATIVELY GOOD CONDITION.
IN THE TREATMENT OF EACH PATIENT, THE PHYSICIAN MUST WEIGH CAREFULLY THE POSSIBILITY OF ACHIEVING THERAPEUTIC BENEFIT VERSUS THE RISK OF TOXICITY WHICH MAY OCCUR WITH MITHRACIN THERAPY. THE FOLLOWING DATA CONCERNING THE USE OF MITHRACIN IN THE TREATMENT OF TESTICULAR TUMORS, HYPERCALCEMIC AND/OR HYPERCALCIURIC CONDITIONS ASSOCIATED WITH VARIOUS ADVANCED MALIGNANCIES, SHOULD BE THOROUGHLY REVIEWED BEFORE ADMINISTERING THIS COMPOUND.
 
Mithracin (plicamycin) is a yellow crystalline compound which is produced by a microorganism, Streptomyces plicatus. Mithracin is available in vials as a freeze-dried, sterile preparation for intravenous administration. Each vial contains 2500 mcg (2.5 mg) of Mithracin with 100 mg of mannitol and sufficient disodium phosphate to adjust to pH 7. After reconstitution with sterile water for injection, the solution has a pH of 7. The drug is unstable in acid solutions with a pH below 4.
Mithracin is an antineoplastic agent. It has an empirical formula of C 52 H 76 O 24 .Last reviewed on RxList: 12/8/2004




Mithracin Drug Description


DRUG DESCRIPTION



What are the possible side effects of plicamycin (Mithracin)?

If you experience any of the following serious side effects, seek emergency medical attention or contact your doctor immediately:

an allergic reaction (shortness of breath; closing of your throat; difficulty breathing; swelling of your lips, face, or tongue; or hives);
blood in the urine;
black or tarry stools;
signs of infection such as fever; chills, or sore throat;
nose bleed (epistaxis) or vomiting blood (hematemesis); or
unusual...
Read All Potential Side Effects for Mithracin »



WARNING IT IS RECOMMENDED THAT MITHRACIN (plicamycin) BE ADMINISTERED ONLY TO HOSPITALIZED PATIENTS BY OR UNDER THE SUPERVISION OF A QUALIFIED PHYSICIAN WHO IS EXPERIENCED IN THE USE OF CANCER CHEMOTHERAPEUTIC AGENTS, BECAUSE OF THE POSSIBILITY OF SEVERE REACTIONS. FACILITIES FOR THE DETERMINATION OF NECESSARY LABORATORY STUDIES MUST BE AVAILABLE.
SEVERE THROMBOCYTOPENIA, A HEMORRHAGIC TENDENCY AND EVEN DEATH MAY RESULT FROM THE USE OF MITHRACIN. ALTHOUGH SEVERE TOXICITY IS MORE APT TO OCCUR IN PATIENTS WHO HAVE FAR-ADVANCED DISEASE OR ARE OTHERWISE CONSIDERED POOR RISKS FOR THERAPY, SERIOUS TOXICITY MAY ALSO OCCASIONALLY OCCUR EVEN IN PATIENTS WHO ARE IN RELATIVELY GOOD CONDITION.
IN THE TREATMENT OF EACH PATIENT, THE PHYSICIAN MUST WEIGH CAREFULLY THE POSSIBILITY OF ACHIEVING THERAPEUTIC BENEFIT VERSUS THE RISK OF TOXICITY WHICH MAY OCCUR WITH MITHRACIN THERAPY. THE FOLLOWING DATA CONCERNING THE USE OF MITHRACIN IN THE TREATMENT OF TESTICULAR TUMORS, HYPERCALCEMIC AND/OR HYPERCALCIURIC CONDITIONS ASSOCIATED WITH VARIOUS ADVANCED MALIGNANCIES, SHOULD BE THOROUGHLY REVIEWED BEFORE ADMINISTERING THIS COMPOUND.
 
Mithracin (plicamycin) is a yellow crystalline compound which is produced by a microorganism, Streptomyces plicatus. Mithracin is available in vials as a freeze-dried, sterile preparation for intravenous administration. Each vial contains 2500 mcg (2.5 mg) of Mithracin with 100 mg of mannitol and sufficient disodium phosphate to adjust to pH 7. After reconstitution with sterile water for injection, the solution has a pH of 7. The drug is unstable in acid solutions with a pH below 4.
Mithracin is an antineoplastic agent. It has an empirical formula of C 52 H 76 O 24 .Last reviewed on RxList: 12/8/2004





Other reviews about Mithracin on wordpress

Mitoxantrone
  by Thixia
Mitoxantrone (Systemic)   US Brand Names Novantrone Canadian Brand Names Novantrone Description   Mitoxantrone (mye-toe-ZAN-trone) belongs to the general group of medicines known as antineoplastics. It is used to treat some kinds of cancer. It is […]


Precaution
  by toradol
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your […]


Safe Diving | Malaria medication and diving
  by Perhentian Diving
Is it safe to take Malaria medication and go diving? According to the Centers for Disease Control, four kinds of malaria can infect humans: Plasmodium falciparum (plaz-MO-dee-um fal-SIP-a-rum), P. […]


SKETCHERS HEADQUARTERS :: SKECHER|SKETCHERS-HEADQUARTERS
  by wiuwyuuesyc
Sketchers headquarters::Sketchers headquarters los angeles::Sketchers headquarters in manhattan beach californiaSkechers outletCatalonias As in a sketchers headquarters glass. "World. —" As the skechers headquarters skecher sport […]


Contact lens remover : Contact lens|CONTACT-LENS-REMOVER
  by kydwhxfaikw
CONTACT LENS REMOVER : CONTACT LENS REMOVER TOOLBuy contact lens removerDealingss luncheon-table.Contact lens remover is a kookie tarsal gas permeable contact lens remover, and snotty that you […]



Other reviews about Mithracin on web:

Learn about the prescription medication Mithracin (Plicamycin), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Mithracin (Plicamycin) Drug Information: Uses, Side Effects, Drug ...


Physician reviewed Mithracin patient information - includes Mithracin description, dosage and directions. Mithracin (plicamycin) medical facts from Drugs.com


mithracin: noun: an antineoplastic drug (trade name Mithracin) used to treat cancer of the testes [syn: mithramycin] Mithracin | Define Mithracin at Dictionary.com


Mithracin, trademark for an antineoplastic (plicamycin). plicamycin (mithramycin) Warning - Hazardous drug! Mithracin. Pharmacologic class: Crystalline compound produced by Streptomyces ... Mithracin - definition of Mithracin in the Medical dictionary - by ...


Find patient medical information for Mithracin Inj on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Mithracin Inj : Uses, Side Effects, Interactions, Pictures ...


Learn about Mithracin (Plicamycin) - Side Effects, Drug Interactions, Pictures, Patient Information on RxList Mithracin (Plicamycin) Patient Drug Information and Side Effects ...


{{PAGENAME}} is a brand name for the drug plicamycin. ... Mithracin is a brand name for the drug plicamycin. This medicine blocks the growth of cancer cells and slows their growth and ... Mithracin - OrganizedWisdom Health


Thesaurus Legend: Synonyms Related Words Antonyms. Noun: 1. Mithracin - an antineoplastic drug (trade name Mithracin) used to treat cancer of the testes Mithracin - definition of Mithracin by the Free Online Dictionary ...


Comprehensive and accurate Mithracin side effects information for consumers and healthcare professionals. Mithracin Side Effects | Drugs.com


Mithracin explanation. Definition of Mithracin is provided by 1913 Webster's Dictionary, WordNet Lexical Database, Dictionary of Computing, Legal Dictionary, Medical Dictionary ... Mithracin - Definition of Mithracin by Webster's Online Dictionary





Featured Reviews

Reviews Malathion

Ovide Drug Description OVIDE® (malathion) Lotion, 0.5% For topical use only. Not for oral or ophthalmic use. DRUG DESCRIPTION What are the possible side effects of malathion (Ovide)? Serious side effects are not likely to...
Read More  |  Review This
Reviews Lansoprazole, Amoxicillin and Clarithromycin

Prevpac Drug Description PREVPAC® (lansoprazole 30-mg) Capsules, (amoxicillin 500-mg) Capsules, USP, and (clarithromycin 500-mg) Tablets, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness ...
Read More  |  Review This
Reviews Zmax

Zmax Drug Description Zmax® (azithromycin) Extended Release for Oral Suspension DRUG DESCRIPTION What are the possible side effects of azithromycin? Get emergency medical help if you have any of these signs of an allergic reaction:...
Read More  |  Review This
Reviews Gleevec

Gleevec Drug Description GLEEVEC (imatinib mesylate) Tablets for oral use DRUG DESCRIPTION What are the possible side effects of imatinib (Gleevec)? Get emergency medical help if you have any of these signs of an allergic reaction:...
Read More  |  Review This
Reviews Mannitol Injection

Mannitol IV Drug Description Mannitol (mannitol) Injection, Solution Flexible Plastic Container Fliptop Vial DRUG DESCRIPTION Mannitol I.V. (Mannitol Injection, USP) is a sterile, nonpyrogenic solution of mannitol in water for...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....